STOCK TITAN
  1. Home
  2. Sec-filings
  3. ELTX
  4. [EFFECT] Elicio Therapeutics, Inc. SEC Filing

[EFFECT] Elicio Therapeutics, Inc. SEC Filing

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
EFFECT

Rhea-AI Filing Summary

Analyzing...
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: March 16, 2026 9:00 A.M.
Form: S-3
CIK: 0001601485
Company Name: Elicio Therapeutics, Inc.
File Number: 333-293861

Source: View Original Filing on SEC EDGAR

Elicio Therapeutics, Inc.

NASDAQ:ELTX

View ELTX Stock Overview →

ELTX Rankings

#4452 Ranked by Market Cap
N/A Ranked by Dividends

ELTX Latest News

Mar 17, 2026
Elicio Therapeutics Reports Inducement Grants
Mar 12, 2026
Elicio Therapeutics Reports Full Year 2025 Financial Results and Provides Corporate Updates
Feb 25, 2026
Elicio Therapeutics to Present at the TD Cowen 46th Annual Health Care Conference
Feb 18, 2026
Elicio Therapeutics Reports Inducement Grants
Jan 16, 2026
Elicio Therapeutics Reports Inducement Grants

ELTX Latest SEC Filings

Mar 16, 2026
[8-K] Elicio Therapeutics, Inc. Reports Material Event
Mar 16, 2026
[424B5] Elicio Therapeutics, Inc. Prospectus Supplement (Debt Securities)
Mar 12, 2026
[S-3/A] Elicio Therapeutics, Inc. Amended Shelf Registration Statement
Mar 12, 2026
[10-K] Elicio Therapeutics, Inc. Files Annual Report
Mar 12, 2026
[8-K] Elicio Therapeutics, Inc. Reports Material Event

ELTX Stock Data

210.56M
11.34M
Biotechnology
Pharmaceutical Preparations
Link
United States
BOSTON